The company publicly launched its platform out of beta after reporting an $8M seed round; the launch also implies a transition from beta-stage product to scaled commercial operations.
SourceWe're building fully automated labs for protein engineering
Public company, workplace, funding, and market signals
Updated Jul 28, 2026
Adaptyv Bio is a Swiss biotechnology company operating an automated cloud laboratory for protein designers. It closes the design–test–learn loop by synthesizing, expressing, purifying and experimentally characterizing AI-designed proteins, returning structured data in roughly three weeks. The platform is used for therapeutic proteins, enzymes and functional materials.
Primary product
Adaptyv Cloud Lab / Foundry: an online, API-accessible wet-lab platform for ordering and analyzing protein expression, binding and thermostability experiments.
Founded
2021
Headquarters
Lausanne / Épalinges, Switzerland (Biopôle Life Science Campus, Route de la Corniche 5, 1066 Épalinges)
Team size
30–40 (public LinkedIn-derived estimate in July 2026; YC reported 25 in April 2023)
Work style
Flexible
Industry
Biotechnology Research
34 jobs at Adaptyv
Sub-industry
AI-enabled protein engineering, automated laboratories and cloud laboratory services
Offices
Business model
Stage
Seed / generating revenue
Total raised
$11.2M
Latest round
Seed · Sep 2025
Latest amount
$8M
Sep 2025 · ACE Ventures
Feb 2025 · ACE Ventures
Jan 2024
Feb 2022 · Wingman Ventures
Leadership
Co-founder and CEO
Daniel Nakhaee-Zadeh Gutierrez
Co-founder; Operations / CTO reported by YC
Lab Automation Engineer; listed on the current team page
Lab Automation Engineer; listed on the current team page
Senior Laboratory Automation Engineer; listed on the current team page
Marylou Favre
Biology team
Odeta Bondarevaite
Biology team
Paul Prevel
Software team
Investors
The careers page emphasizes data-driven engineering, first-principles thinking, action orientation, strong work ethic and cross-disciplinary collaboration among molecular biology, lab automation, software engineering and machine learning teams.
Work style
Flexible
Compensation
No reliable public salary bands or equity terms were found. Public job pages expose roles but not compensation; visa sponsorship is likewise not confirmed.
Benefits
Pricing
Transparent per-protein pricing starting at approximately $149 per protein, including two replicates; additional/custom assays and API/enterprise usage may be separately quoted.
Differentiators
Technology
Customers
Competitors
Estimated revenue
Approximately $1M–$10M annually; third-party estimates range from about $1M to $2.6M, so this is directional rather than company-reported.
Estimated monthly visits
15.6K
The company publicly launched its platform out of beta after reporting an $8M seed round; the launch also implies a transition from beta-stage product to scaled commercial operations.
SourceThe latest financing is reported as an $8M seed round, with plans to expand infrastructure, assays and team; no public layoff, acquisition or shutdown evidence was found.
SourceAdaptyv Bio · May 2026
Adaptyv announced a Benchling Direct Ordering integration for expression, binding and thermostability assays.
Adaptyv Bio · Apr 2026
Adaptyv released an API for catalogue queries, experiment creation, cost estimates and structured JSON results; Tamarind Bio and Phylo are cited as integrations.
Greater Geneva Bern area · Oct 2025
Coverage describes the Lausanne-area company’s automated design-test-learn platform, prior CHF2.5M pre-seed financing and planned assay, automation and API expansion.
ACE Ventures · Sep 2025
The round included byFounders, Founderful, LongGame and angels; the company reported more than 30 organizations using the platform and over 10,000 proteins tested in 2025.
Adaptyv Bio · Sep 2025
Adaptyv announced public availability of its cloud lab after beta, alongside news of an $8M seed round led by ACE Ventures.